Showing results (371-380 of 461) with videos related to

Sort By:
Pageof 47
AIDS Research and Human Retroviruses|August 9, 2016
Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral ControllersGamze Isitman, Irene Lisovsky, Alexandra Tremblay-McLean, et al.
La Revue De Medecine Interne|January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]C Mathiot, B Grosbois, J L Teillaud, et al.
AIDS (London, England)|July 11, 2008
A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infectionSalix Boulet, Marianna Kleyman, Jenice Yj Kim, et al.
Journal of Immunological Methods|January 16, 2007
A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responsesSalix Boulet, Michel L Ndongala, Yoav Peretz, et al.
Journal of Clinical Immunology|January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myelomaC Mathiot, J L Teillaud, M Elmalek, et al.
Journal of Reproductive Immunology|November 15, 2017
Characterization of myeloid cell populations in human testes collected after sex reassignment surgeryRosalie Ponte, Franck P Dupuy, Fadi Brimo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor sizeM de Jong, W A Breeman, B F Bernard, et al.
Nuclear Medicine and Biology|January 15, 1998
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in ratsW A Breeman, M de Jong, B F Bernard, et al.
Pageof 47